Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Apoptosis is crucial for healthy skin and treating skin diseases.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

High levels of the seizure medication sodium valproate can cause hair loss.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.